ИСТОРИЧЕСКАЯ ЭВОЛЮЦИЯ ПАРАДИГМЫ ЭКЛАМПСИИ/ ПРЕЭКЛАМПСИИ

Библиографические ссылки:

Ghulmiyyah L., Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36(1):56-59.

Zweifel P. Eklampsie. In: Dederlein A. (Ed.) Handbuch Der Geburtshilfe. Bergman; 1916: 672–723.https://doi.org/10.1159 / 000354200

Roberts J.M., Bell M.J. If we know so much about preeclampsia, why haven’t we cured the disease? J. Reprod. Immunol. 2013; 99:1-9https://doi.org/10.1016/j.jri.2013.05.003

Robillard P.Y., Scioscia M., Coppola D. La Donna di Ostuni, a case of eclampsia 28,000 years ago. J. Matern. Fetal Neonatal Med. 2017; 24: 1–4.https://doi.org/10.1080/14767058.2017.1312333

Bell M.J. A historical overview of preeclampsia-eclampsia. J. Obstet. Gynecol. Neonatal. Nurs. 2010; 39 (5): 510–518.https://doi.org/10.1111/j.1552-6909.2010.01172.x

Rayer P.E. (Ed.) Traité Des Maladies Des Reins Et Des Altérations De La sécrétion Urinaire. Baillières, Paris; 1840: 1837-1841

Lever J. Cases of Puerperal Convulsions with Remarks 2. Guy’s Hospital Report. London; 1843: 495–517

Johns R. Observations of puerperal convulsions. Dublin J. Med. Sci. 1843. 24 (1):101–115.

Bell M.J. A historical overview of preeclampsia-eclampsia. J. Obstet. Gynecol. Neonatal. Nurs. 2010. 39 (5):510–518.https://doi.org/10.1111/j.1552-6909.2010.01172.x

Vaquez N. De la pression artérielle dans l’éclampsie puerpérale. Bull. Soc. Med. Hop. Paris 1897; 119: 14

Lindheimer M.D., Roberts J.M., Cunnigham F.G., Chesley L. Introduction, history, controversies and definitions. In: Lindheimer J.M., Roberts F.G., Cunningham F.G. (Eds.). Chesley’s Hypertensive Disorders in Pregnancy. Appelton and Lange, Stamford, Connecticut; 1999: 3-41.https://doi.org/10.1016/j.jri.2017.09.006

Robillard P.Y., Dekker G.A., Chaouat G. et al. Preeclampsia and the 20th century: le siècle des Lumières. Pregnancy Hypertens. 2018;13:107-109.

Brosens I.A., Robertson W.B., Dixon H.G. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet. Gynecol. Annu. 1972; 1: 177-191.

Pijnenborg R., Dixon G., Robertson W.B., Brosens I. Trophoblastic invasion of human deciduas from 8 to 18 weeks of pregnancy. Placenta. 1980; 1 (1): 3-19.https://doi.org/10.1016/S0143-4004(80)80012-9

Espitia O., Fouassier M. Thrombin generation test. Rev Med Interne. 2015; 36(10): 690-693.https://doi.org/10.1016/j.revmed.. 2015.04.013

Robillard P.Y., Hulsey T.C., Périanin J. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet. 1994; 344: 973–975.https://doi.org/10.1016/S0140-6736(94)91638-1

Redman C.W., Sargent I.L. Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 2010; 63 (6): 534–543.https://doi.org/10.1111/j.1600-0897.2010.00831.x

Roberts J.M., Taylor R.N., Musci T.J. et al. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 1989; 161: 1200-1204.https://doi.org/10.1016/0002-9378(89)90665-0

Redman C.W., Sargent I.L. The pathogenesis of pre-eclampsia. Gynecol. Obstet Fertil. 2001. 29 (7-8): 518–522.https://doi.org/10.1016/S1297-9589(01)00180-1

Redman C.W., Sacks G.P., Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 1999; 180 (2): 499-506.https://doi.org/10.1016/S0002-9378(99)70239-5

Redman C.W., Sargent I.L. The pathogenesis of pre-eclampsia. Gynecol. Obstet Fertil. 2001; 29 (7-8): 518–522.https://doi.org/10.1016/S1297-9589(01)00180-1

Roberts J.M., Bell M.J. If we know so much about preeclampsia, why haven’t we cured the disease? J. Reprod. Immunol. 2013; 99: 1-99.https://doi.org/10.1016/j.jri.2013.05.003

Kho E.M., McCowan L.M., North R.A.; SCOPE Consortium. Duration of sexual relationship and its effect on preeclampsia and small For gestational age perinatal outcomes. J. Reprod. Immunol. 2009; 82 (1): 66-73.https://doi.org/10.1016/j.jri.2009.04.011

Robillard P.Y., Dekker G., Iacobelli S., Chaouat G. An essay of reflection: why does preeclampsia exist in humans, and why are there such huge geographical differences in epidemiology? J. Reprod. Immunol. 2016; 114: 44–47.https://doi.org/10.1016/j.jri.2015.07.001

Roberts J.M., Bell M.J. If we know so much about preeclampsia, why haven’t we cured the disease? J. Reprod. Immunol. 2013; 99: 1-99.https://doi.org/10.1016/j.jri.2013.05.003

Levine R.J., Maynard S.E., Qian C. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004; 350 (7): 672-683.

Schmidt M., Dogan C., Birdir C. et al. Placental growth factor: a predictive marker for preeclampsia? Gynakol Geburtshilfliche Rundsch. 2009;49(2):94-9. doi: 10.1159/000197908

Zenerino C., Nuzzo A.M., Giuffrida D., Biolcati M. The HMGB1/RAGE Pro-Inflammatory Axis in the Human Placenta: Modulating Effect of Low Molecular Weight Heparin. Molecules. 2017; 22(11).https://doi.org/10.3390/molecules22111997

Scioscia M., Noventa M., Cavallin F. Exploring strengths and limits of urinary D-chiro inositol phosphoglycans (IPG-P) as a screening test for preeclampsia: A systematic review and metaanalysis. J Reprod Immunol. 2019 Sep;134-135:21-27. doi: 10.1016/j.jri.2019.07.005

Момот А.П., Николаева М.Г., Сердюк Г.В., Елыкомов В.А., Мамаев А.Н., Романов В.В., Фадеева Н.И., Кудинова И.Ю., Белозеров Д.Е., Трухина Д.А., Максимова Н.В., Вахлова Ж.И. Оценка состояния системы гемостаза при физиологически протекающей беременности. Методические рекомендации. Российский вестник акушера-гинеколога. 2018; 3.

Chu A.J. Tissue Factor, Blood Coagulation, and Beyond: An Overview. International Journal of Inflammation. 2011; Article ID 367284.https://doi.org/10.4061/2011/367284

Osterud B., Bjorklid E. Sources of tissue factor. Seminars in Thrombosis and Hemostasis. 2006;32(1):11-23. DOI: 10.1055 / s-2006-933336

Mackman N. Role of Tissue Factor in Haemostasis, Thrombosis, and Vascular Development. Arterioscler Thromb Vasc Biol. 2004; 24:1015-1022. DOI: 10.1161 /01.ATV.0000130465.23430.74

Marmur J.D., Thiruvikraman S.V., Fyfe B.S., Guha A., Sharma S.K., Ambrose J.A., Fallon J.T., Nemerson Y., Taubman M.B. Identification of active tissue factor in human coronary atheroma. Circulation. 1996;94:1226-1232.

Belting M., Ahamed J., Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arteiroscler Thromb Vasc Biol. 2005;25:1545-1550.https://doi.org/10.1161/01.ATV.0000171155.05809.bf

Chen D., Riesbeck K., McVey J.H., Kemball-Cook G., Tuddenham E.G., Lechler R.I., Dorling A. Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins. Xenotransplantation. 2001;8(4):258-265.

Sandset P.M. Tissue factor pathway inhibitor (TFPI) – an update. Haemostasis. 1996; 26:154-165. DOI: 10.1159 / 000217293

Broze Jr G.J. Tissue factor pathway inhibitor. Thromb Haemost. 1995;74:90-93.

Di Paolo S., Volpe P., Grandaliano G. Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. J Nephrol. 2003;16:650-657. doi:10.1016/j.ajog.2005.10.813

Dusse L.M., Carvalho M.G., Getliffe K., Voegeli D., Cooper A.J., Lwaleed B.A. Total plasma tissue factor pathway inhibitor levels in pre-eclampsia. Clin Chim Acta. 2008;388:230-232.https://doi.org/10.1016/j.cca.2007.10.029

Rousseau A., Favier R., Van Dreden P. Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol. 2009;146:46-49.https://doi.org/10.1016/j.ejogrb.2009.06.001

Erez O., Romero R., Hoppensteadt D., Than N.G. Tissue factor and its natural inhibitor in preeclampsia and SGA. J Matern Fetal Neonatal Med. 2008;21:855-869. DOI : 10.1080 / 14767050802361872

Teng Y., Jiang R., Lin Q., Ding C., Ye Z. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients. Thromb Res. 2010;.126:.e41-5.https://doi.org/10.1016/j.thromres.2010.02.012

Xiong Y., Zhou Q., Jiang F., Zhou S., Lou Y., Guo Q., Liang W., Kong D., Ma D., Li X. Changes of plasma and placental tissue factor pathway inhibitor-2 in women with preeclampsia and normal pregnancy. Thrombosis Research. 2010. 125:e317–e322.https://doi.org/10.1016/j.thromres.2010.02.017..

Abdel Gader A.M., Al-Mishari A.A., Awadalla S.A., Buyuomi N.M., Khashoggi T., AlHakeem M. Total and free tissue factor pathway inhibitor in pregnancy hypertension. International Journal of Gynaecology and Obstetrics. 2006. 95:248–253.https://doi.org/10.1016/j.ijgo.2006.07.014..

Mastrolia S.A., Mazor M., Loverro G., Klaitman V., Erez O. Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes. Peer J. 2014;2:e653. doi: 10.7717 / peerj.653

Rolnik D.L., Wright D., Poon L.C., O’Gorman N. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017. DOI: 10.1056 / NEJMoa1704559